FDA Approved 13 Drugs in September 2026
The U.S. Food and Drug Administration approved 13 drugs in September 2026, including first-in-class therapies, rare-disease treatments and new options for serious conditions.
The U.S. Food and Drug Administration approved 13 drugs in September 2026, including first-in-class therapies, rare-disease treatments and new options for serious conditions.